承担课题
项目编号：20ZR1451300；名称：类胰蛋白酶通过PAR2/细胞骨架相关蛋白4调控心房成纤维细胞活化的分子机制；上海市自然科学基金面上项目；2020.7—2023.6；（在研）。
项目编号：81300136；名称：类胰蛋白酶激活心房成纤维细胞的机制研究；国家自然科学基金青年基金项目；2014.1—2016.12；（已结题）。
发表论文
Tan H, Chen Z, Chen F, Xu W, Liu X. CKAP4 participates in tryptase-induced phenotypic conversion in atrial fibroblasts through PAR2/p38/JNK pathway. Am J Transl Res. 2021 Apr 15;13(4):2270-2282.
Tan H, Chen Z, Chen F, Yao Y, Lai Y, Xu W, Liu X.Tryptase Promotes the Profibrotic Phenotype Transfer of Atrial Fibroblasts by PAR2 and PPARγ Pathway.Arch Med Res. 2018 Nov;49(8):568-575.
谭红伟等. 起源于左冠窦及右冠窦的室性早搏心电图特征分析及射频消融治疗. 国际心血管病杂志. 2016, 43(3):49-52.
谭红伟等.压力感知导管消融治疗房颤的效果观察. 山东医药. 2016, 56（17）44-46.
谭红伟等. 心房颤动围手术期抗凝治疗策略.国际心血管病杂志. 2015,42(3):147-150.
Tan HW, Wang XH, Shi HF, Zhou L, Gu JN, Liu X*. Left atrial wall thickness:anatomic aspects relevant to catheter ablation of atrial fibrillation.Chin Med J (Engl). 2012; 125(1):12-5.
Tan HW, Wang XH, Shi HF, Sun YM, Zhou L, Gu JN, Han B, Jiang WF, Yang GS, Liu X. Congestive Heart Failure After Extensive Catheter Ablation for Atrial Fibrillation: Prevalence, Characterization, and Outcome. J Cardiovasc Electrophysiol. 2011; 22(6):632-637.
Tan HW, Wang XH, Shi HF, Yang GS, Zhou L, Gu JN, Jiang WF, Liu X. Efficacy, safety and outcome of catheter ablation for atrial fibrillation in octogenarians. Int J Cardiol. 2010; 145 (1):147-148.
Tan HW, Liu X, Bi XP, Xing SS, Li L, Gong HP, Zhong M, Wang ZH, Zhang Y, Zhang W. IL-18 overexpression promotes vascular inflammation and remodeling in a rat model of metabolic syndrome. Atherosclerosis. 2010; 208(2):350-357.
